Cargando…

Production of infectious HCV genotype 1b virus in cell culture using a novel Set of adaptive mutations

BACKGROUND: Despite the high prevalence of genotype 1b hepatitis C virus (HCV) among patients, a cell culture system that permits entire viral life cycle of genotype 1b isolates is limited. To develop a cell-cultured hepatitis C virus (HCVcc) of genotype 1b, the proper combination of HCV genomic var...

Descripción completa

Detalles Bibliográficos
Autores principales: Mori, Ken-ichi, Matsumoto, Akihiro, Maki, Noboru, Ichikawa, Yuki, Tanaka, Eiji, Yagi, Shintaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039931/
https://www.ncbi.nlm.nih.gov/pubmed/27678340
http://dx.doi.org/10.1186/s12866-016-0846-9
_version_ 1782456151643783168
author Mori, Ken-ichi
Matsumoto, Akihiro
Maki, Noboru
Ichikawa, Yuki
Tanaka, Eiji
Yagi, Shintaro
author_facet Mori, Ken-ichi
Matsumoto, Akihiro
Maki, Noboru
Ichikawa, Yuki
Tanaka, Eiji
Yagi, Shintaro
author_sort Mori, Ken-ichi
collection PubMed
description BACKGROUND: Despite the high prevalence of genotype 1b hepatitis C virus (HCV) among patients, a cell culture system that permits entire viral life cycle of genotype 1b isolates is limited. To develop a cell-cultured hepatitis C virus (HCVcc) of genotype 1b, the proper combination of HCV genomic variants and host cells is essential. HCV genomes isolated from patients with distinctive symptoms may provide the variants required to establish an HCVcc of genotype 1b. RESULTS: We first established subgenomic replicons in Huh7 cells using HCV cDNAs isolated from two patients: one with fulminant hepatitis after liver transplantation (TPF1) and another with acute hepatitis and moderate symptoms (sAH). Replicons established from TPF1 and sAH showed mutations in NS4B and in NS3 and NS5A, respectively. Using these replication machineries, we constructed HCV genomic RNAs for each isolate. Virus infectivity was evaluated by a focus-forming assay, which is dependent on the intracellular expression of core antigen, and production of virus particles was assessed by density-gradient centrifugation. Infectious virus was only observed in the culture medium of cells transfected with TFP1 HCV RNA. A chimeric genome with the structural segment (5′-untranslated region [UTR] through NS2) from sAH and the replication machinery (NS3 through 3′-UTR) from TPF1 exhibited greater infectivity than did TFP1, despite formation of deficient virus particles in sAH, suggesting that this genomic segment potentiates virus particle formation. To identify the responsible variants, infectious virus formation was assessed in a chimeric genome carrying parts of the sAH structural segment of the TPF1 genome. A variant in NS2 (M170T) was identified that enhanced infectious virus formation. HCVcc carrying an NS2 gene encoding the M170T substitution and adaptive mutations in NS4B (referred to as TPF1-M170T) infected naïve cured Huh7 cells in a CD81-dependent manner. CONCLUSIONS: We established a novel HCVcc of genotype 1b in Huh7 cells by introducing an amino acid variant in NS2 and adaptive mutations in NS4B from HCV genomic RNA isolated from a patient with fulminant HCV after liver transplantation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12866-016-0846-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5039931
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-50399312016-10-05 Production of infectious HCV genotype 1b virus in cell culture using a novel Set of adaptive mutations Mori, Ken-ichi Matsumoto, Akihiro Maki, Noboru Ichikawa, Yuki Tanaka, Eiji Yagi, Shintaro BMC Microbiol Research Article BACKGROUND: Despite the high prevalence of genotype 1b hepatitis C virus (HCV) among patients, a cell culture system that permits entire viral life cycle of genotype 1b isolates is limited. To develop a cell-cultured hepatitis C virus (HCVcc) of genotype 1b, the proper combination of HCV genomic variants and host cells is essential. HCV genomes isolated from patients with distinctive symptoms may provide the variants required to establish an HCVcc of genotype 1b. RESULTS: We first established subgenomic replicons in Huh7 cells using HCV cDNAs isolated from two patients: one with fulminant hepatitis after liver transplantation (TPF1) and another with acute hepatitis and moderate symptoms (sAH). Replicons established from TPF1 and sAH showed mutations in NS4B and in NS3 and NS5A, respectively. Using these replication machineries, we constructed HCV genomic RNAs for each isolate. Virus infectivity was evaluated by a focus-forming assay, which is dependent on the intracellular expression of core antigen, and production of virus particles was assessed by density-gradient centrifugation. Infectious virus was only observed in the culture medium of cells transfected with TFP1 HCV RNA. A chimeric genome with the structural segment (5′-untranslated region [UTR] through NS2) from sAH and the replication machinery (NS3 through 3′-UTR) from TPF1 exhibited greater infectivity than did TFP1, despite formation of deficient virus particles in sAH, suggesting that this genomic segment potentiates virus particle formation. To identify the responsible variants, infectious virus formation was assessed in a chimeric genome carrying parts of the sAH structural segment of the TPF1 genome. A variant in NS2 (M170T) was identified that enhanced infectious virus formation. HCVcc carrying an NS2 gene encoding the M170T substitution and adaptive mutations in NS4B (referred to as TPF1-M170T) infected naïve cured Huh7 cells in a CD81-dependent manner. CONCLUSIONS: We established a novel HCVcc of genotype 1b in Huh7 cells by introducing an amino acid variant in NS2 and adaptive mutations in NS4B from HCV genomic RNA isolated from a patient with fulminant HCV after liver transplantation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12866-016-0846-9) contains supplementary material, which is available to authorized users. BioMed Central 2016-09-27 /pmc/articles/PMC5039931/ /pubmed/27678340 http://dx.doi.org/10.1186/s12866-016-0846-9 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Mori, Ken-ichi
Matsumoto, Akihiro
Maki, Noboru
Ichikawa, Yuki
Tanaka, Eiji
Yagi, Shintaro
Production of infectious HCV genotype 1b virus in cell culture using a novel Set of adaptive mutations
title Production of infectious HCV genotype 1b virus in cell culture using a novel Set of adaptive mutations
title_full Production of infectious HCV genotype 1b virus in cell culture using a novel Set of adaptive mutations
title_fullStr Production of infectious HCV genotype 1b virus in cell culture using a novel Set of adaptive mutations
title_full_unstemmed Production of infectious HCV genotype 1b virus in cell culture using a novel Set of adaptive mutations
title_short Production of infectious HCV genotype 1b virus in cell culture using a novel Set of adaptive mutations
title_sort production of infectious hcv genotype 1b virus in cell culture using a novel set of adaptive mutations
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039931/
https://www.ncbi.nlm.nih.gov/pubmed/27678340
http://dx.doi.org/10.1186/s12866-016-0846-9
work_keys_str_mv AT morikenichi productionofinfectioushcvgenotype1bvirusincellcultureusinganovelsetofadaptivemutations
AT matsumotoakihiro productionofinfectioushcvgenotype1bvirusincellcultureusinganovelsetofadaptivemutations
AT makinoboru productionofinfectioushcvgenotype1bvirusincellcultureusinganovelsetofadaptivemutations
AT ichikawayuki productionofinfectioushcvgenotype1bvirusincellcultureusinganovelsetofadaptivemutations
AT tanakaeiji productionofinfectioushcvgenotype1bvirusincellcultureusinganovelsetofadaptivemutations
AT yagishintaro productionofinfectioushcvgenotype1bvirusincellcultureusinganovelsetofadaptivemutations